Strong Investment Portfolio Qiming Venture Partners manages a significant fund of 9.5 billion USD, with over 580 companies invested in across technology and healthcare sectors, representing a robust pipeline of innovative and high-growth potential clients.

Successful Exits & Unicorns With more than 210 exits through IPOs and M&A, along with over 80 unicorn and super unicorn companies, Qiming indicates a proven track record of nurturing startups to maturity, highlighting opportunities to engage with portfolio companies at different growth stages.

Focused Sector Expertise Qiming’s concentrated investments in cutting-edge technology and healthcare, coupled with recent funding rounds into biotech and medical device firms, create potential sales avenues for companies supplying industry-specific solutions and innovative products.

Active Funding Engagements Recent investments exceeding 100 million USD into pre-IPO and Series funding rounds demonstrate ongoing capital deployment, offering opportunities to pitch financial, technological, and consulting services to startups preparing for public offerings.

Global Industry Recognition Recognition as a top-performing fund and leadership acknowledgment attract attention from institutional investors and portfolio companies seeking collaborations, presenting opportunities for partnership development, sponsorship, and technology integration.